Tumor Recurrence Clinical Trial
Official title:
Phase II Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies
The study aims to obtain a local control rate in patients with lateral pelvic relapses of gynecologycal cancers previously irradiated. High LET (Linear Energy Transfer) particles as carbon ions can guarantee a biologic advantage compared to photons in radioresistant neoplasms, given to their higher biological efficacy (RBE).
Primary aim: estimate the effect, in terms of clinical response, of carbon ion treatment (CIRT) in patients with lateral pelvic recurrences of gynecological malignancies. Secondary aims: 1. To describe the safety profile of carbon ion therapy. 2. To estimate the effect, in terms of survival, of carbon ion treatment ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06022029 -
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
|
Phase 1 | |
| Recruiting |
NCT05084586 -
Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation
|
N/A | |
| Not yet recruiting |
NCT05876052 -
HOPE to Reduce Tumour Recurrence After LT In Patients With HCC
|
N/A | |
| Not yet recruiting |
NCT03515369 -
Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma
|
Phase 4 | |
| Recruiting |
NCT03383094 -
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
|
Phase 2 | |
| Not yet recruiting |
NCT05704231 -
The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer
|
N/A |